Typcal, a pioneering Latin American foodtech specializing in mycelium fermentation, has announced ambitious plans for significant growth and international expansion in 2026. The Brazilian company aims to achieve R$ 5 million in annual revenue and is preparing for a Series A funding round to fuel its next phase. This strategic push follows a year of operational consolidation, setting the stage for the company to scale its production of innovative, sustainable food ingredients.
Foundations for Industrial Scale
In 2025, Typcal laid the groundwork for its expansion by investing over R$ 5 million in its first commercial factory located in Paraná, Brazil. This facility marks a critical transition from pilot projects to large-scale commercialization of its mycelium-based ingredients. The move is central to the company's strategy to meet growing market demand and establish a robust production pipeline for the global food industry.
The company's growth trajectory was further bolstered by a R$ 2.5 million investment from Biotope, a Belgian venture capital firm. This capital injection has been instrumental in validating Typcal's technology and supporting its early international outreach efforts. The funding underscores investor confidence in the company's potential to disrupt the alternative protein market with its unique fermentation process.
A Global Vision for Mycelium
According to CEO Paulo Ibri, the company's focus has now shifted to achieving industrial scale with predictability and efficiency. He stated that with a validated technology and positive market reception, the goal is to become the most competitive mycelium player globally. This will be achieved through strategic distribution channels and competitive pricing, positioning Typcal as a leader in the emerging sector.
Typcal has distinguished itself by adopting a global-first strategy from its inception, a unique approach in the nascent foodtech space. With established operations in Brazil and a European base in Belgium, the company is also active in Mexico and Chile. This international presence allows Typcal to effectively navigate diverse markets and capitalize on the worldwide demand for sustainable food solutions.
Innovating the Future of Food
The company's core innovation lies in producing protein and fiber-rich ingredients from mycelium, the root structure of fungi. This technology offers a compelling solution that combines strong technical performance, economic viability, and a positive environmental impact. Typcal is well-positioned to address the increasing regulatory and consumer pressure for more sustainable food supply chains across the globe.
Typcal's innovative approach has earned it international recognition, including being named to the prestigious Foodtech 500 list for two consecutive years. The company has also attracted notable investors from outside the traditional venture capital sphere, including celebrated Brazilian volleyball figures Bernardinho and Bruninho. This diverse support highlights the broad appeal and perceived potential of its mission to revolutionize the food industry.
As Typcal enters 2026, its primary objective is to transition its mycelium technology from the laboratory to a prominent position in the global food market. With a clear roadmap for scaling production, securing further investment, and expanding its international footprint, the company is poised to make a significant impact. This next chapter will be crucial in demonstrating the industrial viability of mycelium as a mainstream, sustainable food ingredient.